Skip to main content

CELECOXIB

NDC 75834-237 · NIVAGEN PHARMACEUTICALS, INC.

Generic nameCELECOXIB
Dosage formCAPSULE
RouteORAL
Active ingredient(s)CELECOXIB
Strength100 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

75834-237-01 — 100 CAPSULE in 1 BOTTLE (75834-237-01)

75834-237-05 — 500 CAPSULE in 1 BOTTLE (75834-237-05)

75834-237-11 — 100 CAPSULE in 1 BLISTER PACK (75834-237-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72189-123 — CELECOXIB, 72189-360 — Celecoxib, 72189-662 — Celecoxib, 72241-022 — Celecoxib, 72241-023 — Celecoxib, 72241-024 — Celecoxib, 72241-025 — Celecoxib, 72789-259 — Celecoxib, 72789-582 — Celecoxib, 75834-236 — CELECOXIB, 75834-238 — CELECOXIB, 75834-239 — CELECOXIB, 76420-009 — celecoxib, 76420-243 — celecoxib, 76420-714 — Celecoxib, 76420-726 — Celecoxib, 76420-727 — Celecoxib, 76420-728 — Celecoxib, 76420-842 — Celecoxib, 76420-843 — Celecoxib, +213 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels